U Demel
Overview
Explore the profile of U Demel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tilz G, Diez-Ruiz A, Baier-Bitterlich G, Demel U, Wachter H, Fuchs D
Hematology
. 2016 Jul;
1(2):141-54.
PMID: 27406429
Tumor necrosis factor-α is a pleiotropic cytokine which is capable of inducing numerous immunological and biochemical changes in target cells and tissues, Soluble tumor necrosis factor-α receptors function to modulate...
2.
Demel U, Foldes-Papp Z, Tilz G
Hematology
. 2016 Jul;
6(6):423-8.
PMID: 27405698
In the Goodpasture experiment, we determined a probability of 99.1% of identifying one single immune complex. Under these conditions, a single molecule event is proven. There exist no instrumental assumptions...
3.
Moazedi-Fuerst F, Kielhauser S, Hermann J, Meilinger M, Demel U, Stradner M, et al.
Scand J Rheumatol
. 2015 Sep;
44(6):519-20.
PMID: 26376839
No abstract available.
4.
Yazdani-Biuki B, Stadlmaier E, Mulabecirovic A, Brezinschek R, Tilz G, Demel U, et al.
Ann Rheum Dis
. 2005 Jul;
64(8):1224-6.
PMID: 16014683
Objective: To determine the effect on the humoral immune system of long term treatment of patients with RA with etanercept. Methods: 12 consecutive patients with seropositive RA treated with etanercept...
5.
Domej W, Flogel E, Tilz G, Demel U
Internist (Berl)
. 2005 Apr;
46(7):795-9.
PMID: 15815891
Whether an antibiotic successfully eradicates pathogens depends on the pathogens involved, on pharmacokinetics and bioavailability in the target tissue, and on the antimicrobial resistance of the pathogen. Other determinants are...
6.
Demel U, Tilz G, Foeldes-Papp Z, Gutierrez B, Albert W, Bocher O
J Exp Clin Cancer Res
. 2004 Dec;
23(3):465-8.
PMID: 15595637
Malignant cells in the peripheral blood of patients with solid tumours are of considerable importance for the prognosis and therapeutic correlation. Their detection however is difficult due to lack of...
7.
Hermann J, Demel U, Stunzner D, Daghofer E, Tilz G, Graninger W
Ann Rheum Dis
. 2004 Oct;
64(4):641-3.
PMID: 15485998
Background: While antibodies directed against proteinase 3 (PR3-ANCA) and myeloperoxidase (MPO-ANCA) have a high specificity for the diagnosis of systemic vasculitis, they may also be found as an epiphenomenon of...
8.
Keeling I, Oberwalder P, Anelli-Monti M, Schuchlenz H, Demel U, Tilz G, et al.
Eur J Cardiothorac Surg
. 2002 Dec;
22(6):971-7.
PMID: 12467822
Objectives: In this single-center study we reviewed our experience with a significant number of cardiac myxoma cases occurring over the past two decades. Patients And Methods: Cardiac myxomas represented 86%...
9.
Finke L, Demel U, Klinkhardt K, Nother S
Anthropol Anz
. 2002 Feb;
59(4):309-30.
PMID: 11838045
The distribution of 122 epigenetic traits of the cranium and the postcranial skeleton (180 skeletal individuals) of six sites of the period of the Middleelbe-Saale-Region was analyzed. Based on these...
10.
Cerwenka H, Wolf G, Mischinger H, Cerwenka A, Demel U, Tilz G
Eur J Surg
. 2002 Jan;
167(10):792-4.
PMID: 11775734
No abstract available.